You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sorafenib

Showing 1001 - 1025 of 1,094
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Liver Cancer Trial in Chapel Hill, Durham (sorafenib tosylate)

Terminated
  • Liver Cancer
  • sorafenib tosylate
  • Chapel Hill, North Carolina
  • +1 more
May 22, 2012

Hepatocellular Carcinoma Trial in Germany (Sorafenib)

Terminated
  • Hepatocellular Carcinoma
  • Sorafenib
  • Tübingen, BW, Germany
  • +5 more
Jun 6, 2012

PHENYTOIN/SORAFENIB [VA Drug Interaction], Carcinoma, Hepatocellular Trial in Jinan, Qingdao, Yantai (TACE, sorafenib combined

Unknown status
  • PHENYTOIN/SORAFENIB [VA Drug Interaction]
  • Carcinoma, Hepatocellular
  • TACE
  • sorafenib combined with TACE
  • Jinan, Shandong, China
  • +4 more
May 21, 2012

Carcinoma, Hepatocellular Trial in Seoul (TACE (Transcatheter Arterial Chemoembolization ))

Completed
  • Carcinoma, Hepatocellular
  • TACE (Transcatheter Arterial Chemoembolization )
  • Seoul, Korea, Republic of
    National Cancer Center
May 29, 2012

Non-Small-Cell Lung Carcinoma Trial run by the NCI (BAY 43-9006 (Sorafenib))

Completed
Has Results
  • Non-Small-Cell Lung Carcinoma
  • BAY 43-9006 (Sorafenib)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 3, 2012

PHENYTOIN/SORAFENIB [VA Drug Interaction], Liver Tumors, Carcinoma, Hepatocellular Trial in Jinan (Transarterial

Unknown status
  • PHENYTOIN/SORAFENIB [VA Drug Interaction]
  • +11 more
  • Transarterial Chemoembolization (TACE)
  • Sorafenib in combination with TACE
  • Jinan, Shandong, China
    Shandong Cancer Hospital and Institute
Apr 24, 2012

Malignant Melanoma Trial in Los Angeles, Miami Beach (Sorafenib (BAY 43-9006), ABI-007(Abraxane))

Completed
  • Malignant Melanoma
  • Los Angeles, California
  • +1 more
May 2, 2012

Solid Tumor Trial in Chapel Hill (carboplatin, cisplatin, etoposide)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Apr 20, 2012

Renal Cell Carcinoma Trial in Boston (Radiofrequency Ablation)

Withdrawn
  • Renal Cell Carcinoma
  • Radiofrequency Ablation
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Feb 26, 2013

Liver Cancer Trial in Cleveland (panobinostat, sorafenib tosylate)

Terminated
  • Liver Cancer
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Mar 16, 2012

Unresectable or Metastatic Hepatocellular Carcinoma Trial in Memphis (Temsirolimus)

Unknown status
  • Unresectable or Metastatic Hepatocellular Carcinoma
  • Memphis, Tennessee
    Boston Baskin Cancer Foundation
Dec 13, 2012

Metastatic Renal Cell Carcinoma Trial in Worldwide (RAD001, Placebo)

Completed
Has Results
  • Metastatic Renal Cell Carcinoma
  • Fayetteville, Arkansas
  • +92 more
Dec 7, 2012

Carcinoma, Hepatocellular Trial in Cleveland (Nexavar)

Terminated
  • Carcinoma, Hepatocellular
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Mar 20, 2012

Patients Treated for Advanced Renal Cell Carcinoma With Nexavar

Completed
  • Carcinoma, Renal Cell
  • Carcinoma, Renal Cell (Advanced)
  • Sorafenib (Nexavar, BAY43-9006)
  • Many Locations, Belgium
    (unnamed)
Jun 14, 2012

Breast Cancer Trial in Columbus (Paclitaxel Albumin Nanoparticle for Injectable Suspension (Abraxane), Sorafenib (Nexavar))

Terminated
  • Breast Cancer
  • Paclitaxel Albumin Nanoparticle for Injectable Suspension (Abraxane)
  • Sorafenib (Nexavar)
  • Columbus, Ohio
    Veeda Oncology
May 9, 2012

Hepatocellular Carcinoma Trial in Seoul (sorafenib, TS-1)

Completed
  • Hepatocellular Carcinoma
  • sorafenib, TS-1
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jan 31, 2012

Hepatocellular Carcinoma Non-resectable, Hepatocellular Carcinoma Recurrent, Carcinoma, Hepatocellular Trial in Worldwide

Terminated
  • Hepatocellular Carcinoma Non-resectable
  • +12 more
  • Beverly Hills, California
  • +162 more
Sep 7, 2012

Gastrointestinal Stromal Tumors Trial in Seoul (Sorafenib)

Completed
  • Gastrointestinal Stromal Tumors
  • Sorafenib
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jan 18, 2012

BRAFV600E Intratumor Heterogeneity in Thyroid Cancer Treated

Unknown status
  • Differentiated Thyroid Cancer
    • Baronissi, Salerno, Italy
      Department of Medicine and Surgery, Univeristy of Salerno
    Oct 20, 2012

    Metastatic Renal Cell Carcinoma Trial in France (Temsirolimus, Bevacizumab, Sunitinib)

    Completed
    • Metastatic Renal Cell Carcinoma
    • Angers, France
    • +28 more
    Feb 14, 2013

    Quality of Life Trial in Dhaka (Oncoxin, Suranix)

    Unknown status
    • Quality of Life
    • Dhaka, Bangladesh
      Farabi General Hospital
    Dec 11, 2012

    Hepatic Tumor Malignant Trial (oxaliplatin (SR96669), capecitabine, sorafenib)

    Withdrawn
    • Hepatic Neoplasm Malignant
    • oxaliplatin (SR96669)
    • +2 more
    • (no location specified)
    Nov 8, 2011

    Cognitive Function of Patients With Sunitinib or Sorafenib

    Completed
    • Metastatic Renal Cell Cancer
    • GIST
      • Nijmegen, Gelderland, Netherlands
        University Medical Centre Nijmegen
      Nov 1, 2011

      Carcinoma, Renal Cell, Glioblastoma, Carcinoma, Hepatocellular Trial (Crizotinib plus VEGF inhibitor combinations, Crizotinib

      Withdrawn
      • Carcinoma, Renal Cell
      • +2 more
      • Crizotinib plus VEGF inhibitor combinations
      • +4 more
      • (no location specified)
      Dec 19, 2011

      Bladder Cancer Trial (Sorafenib, Placebo)

      Terminated
      • Bladder Cancer
      • Sorafenib
      • Placebo
      • (no location specified)
      Sep 7, 2011